Immunovant Email Format
Biotechnology Research
・
201-500 employees
・
New York, NY, USA
Immunovant is a clinical-stage biotechnology company developing innovative anti-FcRn therapies to treat autoimmune diseases and enable normal lives for patients worldwide.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@immunovant.com
Company Overview
Industry
Biotechnology Research
Founded
2018
Headquarters
New York, NY, USA
Revenue
$25M-$50M
FUNDING Stage
Public
Website
Key Executives
Eric Venker (Chief Executive Officer), Tiago Girao (Chief Financial Officer), Melanie Gloria (Chief Operating Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Immunovant?
Immunovant uses the first.last format, so Jane Smith would be jane.smith@immunovant.com.
What is Immunovant's lead pipeline asset and how many indications is it being studied in?
Immunovant's lead asset is IMVT-1402, a subcutaneous anti-FcRn antibody being studied across six autoimmune indications including Graves' Disease, Myasthenia Gravis, Rheumatoid Arthritis, Sjögren's Disease, CIDP, and Cutaneous Lupus Erythematosus.
Which therapeutic areas does Immunovant focus on in its clinical research?
Immunovant conducts clinical research across endocrinology, rheumatology, neurology, and dermatology, with all programs centered on treating autoimmune diseases. Tools like Clay can help you identify and reach the right Immunovant research contacts within these disease areas.
Who leads Immunovant as CEO?
Eric Venker serves as Chief Executive Officer of Immunovant. The executive leadership team also includes Tiago Girao as Chief Financial Officer and Melanie Gloria as Chief Operating Officer.
Where is Immunovant headquartered and how large is the company?
Immunovant is headquartered in New York, NY, and has approximately 329 employees. If you need to verify or enrich contact details for Immunovant employees, Clay is a useful tool for building accurate prospect lists.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating